Function Blocking Autoantibodies Against Matrix Metalloproteinase-1 in Patients with Systemic Sclerosis
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (4), 542-547
- https://doi.org/10.1046/j.1523-1747.2003.12097.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma)Genes & Immunity, 2001
- Matrix metalloproteinases in skinExperimental Dermatology, 1997
- Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) May Be an Autocrine Growth Factor in Scleroderma Fibroblasts.Journal of Investigative Dermatology, 1997
- Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosisJournal of the American Academy of Dermatology, 1995
- Myofibroblasts from Scleroderma Skin Synthesize Elevated Levels of Collagen and Tissue Inhibitor of Metalloproteinase (TIMP-1) with Two Forms of TIMP-1Journal of Biological Chemistry, 1995
- Decreased Collagenase Expression in Cultured Systemic Sclerosis FibroblastsJournal of Investigative Dermatology, 1994
- Antihistone Antibodies in Systemic SclerosisArthritis & Rheumatism, 1994
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Characterization of dermal collagen in systemic sclerosisBritish Journal of Dermatology, 1979